Yu Su

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Aging-related metabolic dysregulation in osteoporosis: mechanisms and therapeutic strategies.

Aging-related metabolic dysregulation in osteoporosis: mechanisms and therapeutic strategies.

Journal: Frontiers in aging

Published: May 20, 2026

Global Burden and Temporal Trends of Brain and Central Nervous System Tumors in Children and Adolescents: A Systematic Analysis for the Global Burden of Disease Study 2021.

Global Burden and Temporal Trends of Brain and Central Nervous System Tumors in Children and Adolescents: A Systematic Analysis for the Global Burden of Disease Study 2021.

Journal: Cancer innovation

Published: December 30, 2025

Quantitative liquid chromatography-tandem mass spectrometric analysis of 11dH-TXB2 and creatinine in urine.

Quantitative liquid chromatography-tandem mass spectrometric analysis of 11dH-TXB2 and creatinine in urine.

Journal: Acta biochimica et biophysica Sinica

Published: July 19, 2025

An interpretable machine learning model for predicting prognosis of medulloblastoma integrating genetic and clinical features.

An interpretable machine learning model for predicting prognosis of medulloblastoma integrating genetic and clinical features.

Journal: Communications medicine

Published: July 14, 2025

MiR-122-5p modulates ferroptosis via SLC7A11: A potential therapeutic target in autoimmune hepatitis.

MiR-122-5p modulates ferroptosis via SLC7A11: A potential therapeutic target in autoimmune hepatitis.

Journal: Journal of translational autoimmunity

Published: June 11, 2025

Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapy.

Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapy.

Journal: Med (New York, N.Y.)

Published: April 01, 2025

Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer.

Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer.

Journal: Cell reports. Medicine

Published: March 07, 2025

Circulating Platelet-Neutrophil Aggregates as Novel Biomarker for Coagulopathy Diagnosis and Disseminated Intravascular Coagulation Prediction in Sepsis.

Circulating Platelet-Neutrophil Aggregates as Novel Biomarker for Coagulopathy Diagnosis and Disseminated Intravascular Coagulation Prediction in Sepsis.

Journal: Mediators of inflammation

Published: February 23, 2025

Unveiling spatial heterogeneity in medulloblastoma: A multi-omics analysis of cellular state and geographical organization.

Unveiling spatial heterogeneity in medulloblastoma: A multi-omics analysis of cellular state and geographical organization.

Journal: Neuro-oncology

Published: February 17, 2025

Targeting tumor-associated macrophage-induced IGF1/PI3K/Zic1 axis triggers SHH medulloblastoma regression and chemosensitization.

Targeting tumor-associated macrophage-induced IGF1/PI3K/Zic1 axis triggers SHH medulloblastoma regression and chemosensitization.

Journal: Neuro-oncology

Published: January 18, 2025

Targeting tumor-associated macrophages-induced IGF1/PI3K/Zic1 axis triggers SHH medulloblastoma regression and chemosensitization.

Targeting tumor-associated macrophages-induced IGF1/PI3K/Zic1 axis triggers SHH medulloblastoma regression and chemosensitization.

Journal: Neuro-oncology

Published: January 18, 2025

Immune-mediated liver injury caused by immune checkpoint inhibitors exhibits distinct clinical features that differ from autoimmune hepatitis.

Immune-mediated liver injury caused by immune checkpoint inhibitors exhibits distinct clinical features that differ from autoimmune hepatitis.

Journal: Expert opinion on drug metabolism & toxicology

Published: December 12, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026